Levulan Kerastick
Generic name:aminolevulinic acid hydrochloride
Dosage form: topical solution
Drug class:Topical photochemotherapeutics
Medically reviewed by Drugs.com. Last updated on Jan 24, 2022.
On This Page
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Adverse Reactions/Side Effects
- Drug Interactions
- Use In Specific Populations
- Overdosage
- Description
- Clinical Pharmacology
- Nonclinical Toxicology
- Clinical Studies
- How Supplied/Storage and Handling
- Patient Counseling Information
Indications and Usage for Levulan Kerastick
The Levulan Kerastick for topical solution plus blue light illumination using the BLU-U Blue Light Photodynamic Therapy Illuminator is indicated for the treatment of minimally to moderately thick actinic keratoses of the face, scalp, or upper extremities.
Levulan Kerastick Dosage and Administration
Preparation and Administration Overview
After mixing, the Levulan Kerastick topical solution 20% is intended for direct application to individual lesions diagnosed as actinic keratoses and not to perilesional skin. This product is not intended for application by patients or unqualified medical personnel. Application should involve lesions on the scalp, face or upper extremities; multiple lesions can be treated within a treatment region, but multiple treatment regions should not be treated simultaneously.
The recommended treatment frequency is: one application of the Levulan Kerastick topical solution and one dose of illumination per treatment region per 8-week treatment session. Each individual Levulan Kerastick applicator should be used for only one patient.
Levulan Kerastick photodynamic therapy for actinic keratoses is a two-stage process involving application of the Levulan Kerastick topical solution to the target lesions and then illumination with blue light using the BLU-U Blue Light Photodynamic Therapy Illuminator after 3 hours for upper extremity lesions or after 14-18 hours for face or scalp lesions.
